Key Takeaways
- Gastric cancer often develops slowly, and early symptoms are commonly mistaken for indigestion, bloating, or acid reflux.
- Persistent symptoms of gastric cancer, such as stomach pain, nausea, weight loss, or feeling full quickly, should never be ignored.
- Metastatic gastric cancer occurs when the disease spreads beyond the stomach, most commonly to the liver, lymph nodes, or lungs.
- Treatment options for gastric cancer may include surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy depending on the stage.
- Early diagnosis greatly improves the gastric cancer survival rate, while clinical trials for oncology continue to expand treatment possibilities for advanced cases.
Introduction
Gastric cancer, also known as stomach cancer, develops when malignant cells form in the lining of the stomach. It often grows slowly at first, which makes early diagnosis difficult. Many people mistake warning signs for common digestive problems like acid reflux, bloating, or indigestion. That delay matters.
Gastric cancer remains one of the leading causes of cancer-related deaths worldwide. However, treatment outcomes improve significantly when doctors detect the disease early. Better screening methods, targeted therapies, and clinical trials for oncology are also changing how specialists approach care.
This guide explains the most common gastric cancer symptoms, available treatment options, causes, stages, survival rates, and the growing role of clinical research in improving patient outcomes.
What is Gastric Cancer?
Gastric cancer, also called stomach cancer, begins when cells in the stomach lining grow and multiply abnormally. Most cases, roughly 90–95%, are adenocarcinomas, meaning they originate in the glandular cells of the stomach lining.
It tends to develop slowly over many years. A precancerous change in the stomach lining, called gastric atrophy or intestinal metaplasia, can take years to become malignant. This slow progression is both a problem (it is easy to miss early on) and an opportunity (screening and early intervention can work).
Who Is Most at Risk?
Not everyone faces the same risk. Several factors raise the likelihood of developing gastric cancer:
- H. pylori infection is the single biggest risk factor. This bacterial infection causes chronic stomach inflammation that can, over the years, turn cancerous
- Age and sex play a role. Men over 55 are disproportionately affected
- Diet matters more than most people realize. High intake of salt-cured, smoked, or pickled foods raises the risk
- Smoking roughly doubles the risk of gastric cancer
- Family history of stomach cancer or certain genetic syndromes (like hereditary diffuse gastric cancer) increases vulnerability
- Prior stomach surgery for ulcers can also be a contributing factor
Symptoms of Gastric Cancer Often Overlap with Other Conditions
One of the biggest challenges with diagnosis is that the symptoms of gastric cancer can mimic ulcers, gastritis, or acid reflux.
For example:
- Mild nausea may appear first
- Bloating may worsen after meals
- Patients may avoid eating because of discomfort
- Fatigue may develop gradually due to anemia
Many patients dismiss these symptoms of stomach cancer as stress or poor eating habits. A patient in his early 50s may report months of indigestion before doctors finally order an endoscopy. Another patient may only seek help after rapid weight loss begins. These situations are common in clinical practice.
What Does the Diagnosis Look Like?
The diagnostic process typically involves:
- Upper endoscopy (EGD) — A camera-equipped tube is inserted into the stomach to look for abnormal tissue. Biopsies are taken from suspicious areas
- CT scan of the chest, abdomen, and pelvis to assess the extent of spread
- Endoscopic ultrasound (EUS) to determine how deeply the tumor has invaded the stomach wall
- PET scan in select cases, especially when metastatic gastric cancer is suspected
- HER2 testing on the tumor biopsy, since HER2-positive cancer responds to targeted therapies like trastuzumab
Treatment Options for Gastric Cancer
Treatment depends heavily on the stage at diagnosis, especially metastatic gastric cancer. Here is a breakdown of what current care looks like.
Surgery
For localized cancer (stages I through III), surgery is the primary curative option. A partial gastrectomy removes a portion of the stomach. A total gastrectomy removes it entirely. Surgeons also remove surrounding lymph nodes (lymphadenectomy) to check and reduce the spread.
Minimally invasive laparoscopic techniques are increasingly used for early-stage disease, offering shorter recovery times.
Chemotherapy
Chemotherapy is used in multiple ways:
- Before surgery (neoadjuvant) to shrink the tumor
- After surgery (adjuvant) to reduce recurrence risk
- As a primary treatment for advanced or metastatic gastric cancer, where surgery is not possible
Common regimens include FLOT (fluorouracil, leucovorin, oxaliplatin, docetaxel), FOLFOX, and capecitabine plus oxaliplatin (CAPOX).
Targeted Therapy
For HER2-positive gastric cancer, trastuzumab (Herceptin) added to chemotherapy significantly improves outcomes. This was one of the first major targeted therapy breakthroughs in gastric cancer treatment.
Ramucirumab (Cyramza) targets tumor blood vessel growth and is used in later-line treatment of advanced disease.
Immunotherapy
Immunotherapy has changed the treatment landscape for metastatic gastric cancer. Checkpoint inhibitors like pembrolizumab (Keytruda) and nivolumab (Opdivo) help the immune system recognize and attack cancer cells.
Radiation
Radiation therapy is used selectively in gastric cancer. It is more common in the United States as part of chemoradiation (combined with chemotherapy) after surgery, particularly in cases where surgical margins are close.
Clinical Trials
Patients diagnosed with advanced gastric cancer or gastrointestinal stromal tumors GIST may benefit from emerging therapies being studied through oncology research programs like metastatic gastric cancer clinical studies. Clinical trials continue to explore targeted treatments, immunotherapy, and newer drug combinations designed to improve outcomes and expand future care options for patients facing complex gastrointestinal cancers.
Stages of Gastric Cancer
Doctors stage Gastric Cancer based on tumor depth and spread.
Stage 0 to Stage 1
Cancer remains localized within the stomach lining or nearby tissue.
Stage 2 to Stage 3
The tumor grows deeper and may involve nearby lymph nodes.
Stage 4
Cancer spreads to distant organs.
At this stage, the disease becomes metastatic gastric cancer.
Gastric Cancer Survival Rate: The Real Numbers
The gastric cancer survival rate is often cited as one of the more sobering statistics in oncology. Here is what current data shows (five-year relative survival by stage, based on SEER database):
| Stage | Description | 5-Year Survival Rate |
|---|---|---|
| Stage I | Localized (confined to the stomach wall) | 70–94% |
| Stage II | Regional spread (nearby lymph nodes) | 32–46% |
| Stage III | More extensive lymph node involvement | 18–20% |
| Stage IV | Distant metastasis | 4–6% |
Nutrition During Treatment
Nutrition becomes difficult for many patients with gastric cancer. Smaller meals are often easier to tolerate.
- Helpful dietary strategies include:
- Eating soft foods
- Increasing protein intake
- Avoiding greasy meals
- Staying hydrated
- Limiting highly processed foods
Dietitians frequently work alongside oncology teams to help patients maintain strength during treatment.
Emotional Impact of Gastric Cancer
Cancer affects more than the body. Many patients experience:
- Anxiety
- Depression
- Fear of recurrence
- Social isolation
Support groups and counseling can help patients and families cope during treatment. Some patients benefit from speaking with survivors who have gone through similar experiences.
Final Thoughts
To conclude, gastric cancer is a serious disease with a large global burden. But it is not a death sentence. The trajectory of care has changed meaningfully in the last decade, driven by molecular profiling, immunotherapy, and an expanding pipeline of targeted agents.
The most impactful thing any individual can do is pay attention to persistent symptoms and seek evaluation rather than wait. When caught early, the gastric cancer survival rate is genuinely favorable. When caught late, the options are still growing, particularly for those who pursue clinical trials for oncology.
Additionally, NHO Revive is conducting clinical research studies in Nebraska help find better treatment options for cancer patients. Help us move forward in this noble cause to reshape what the future of a better treatment option could look like.
Frequently Asked Questions
What is the main cause of gastric cancer?
There is no single cause of gastric cancer, but several risk factors increase the likelihood of developing it. One of the most common causes is a long-term infection with Helicobacter pylori (H. pylori), a bacteria that damages the stomach lining over time. Other major risk factors include smoking, heavy alcohol use, chronic gastritis, obesity, family history, and diets high in salty or processed foods.
What is the survival rate for gastric cancer?
The gastric cancer survival rate depends largely on how early the disease is diagnosed. Patients with localized Gastric Cancer generally have a much higher survival rate because treatment can begin before the cancer spreads. Advanced or metastatic gastric cancer typically has lower survival outcomes, although newer therapies, immunotherapy, and targeted treatments are helping improve survival in some patients.
Is gastric cancer curable?
Yes, Gastric cancer can be curable when doctors detect and treat it early. Localized tumors may be removed with surgery, often combined with chemotherapy or radiation therapy. However, advanced or metastatic gastric cancer is usually more difficult to cure completely. In those cases, treatment focuses on controlling the disease, relieving symptoms, and extending survival.
